Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.

Journal of Neurochemistry
Jeff HewettAygul Balcioglu

Abstract

Early onset torsion dystonia (DYT1), the most common form of hereditary primary dystonia, is caused by a mutation in the TOR1A gene, which codes for the protein, torsinA. We previously examined the effect of the human mutant torsinA on striatal dopaminergic function in a conventional transgenic mouse model of DYT1 dystonia (hMT1), in which human mutant torsinA is expressed under the cytomegalovirus promotor. Systemic administration of amphetamine did not increase dopamine (DA) release as efficiently in these mice as compared with wild-type transgenic and non-transgenic mice. We, now, studied the contribution of the DA transporter (DAT) to amphetamine-induced DA release in hMT1 transgenic mice using in vivo no-net flux microdialysis. This method applies different concentrations of DA through the microdialysis probe and measures DA concentration at the output of the probe following an equilibrium period. The slope (extraction fraction) is the measure of the DAT activity in vivo. The slope for hMT1 transgenic mice was 0.58 +/- 0.07 and for non-transgenic animals, 0.87 +/- 0.06 (p < 0.05). We further investigated the efficacy of nomifensine (a specific DAT inhibitor) in inhibiting amphetamine-induced DA release. Local application o...Continue Reading

References

Jan 1, 1986·Psychopharmacology·N M RupniakC D Marsden
Jul 1, 1993·Journal of Neuroscience Methods·J B Justice
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P V PiazzaM Le Moal
Sep 1, 1997·Nature Genetics·L J OzeliusX O Breakefield
Nov 14, 1997·Trends in Biochemical Sciences·A LupasW Baumeister
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·S R JonesM G Caron
Nov 30, 1999·Annals of Neurology·S J AugoodD G Standaert
Jul 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·M R PlaczekT T Warner
Jul 28, 2001·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·T Ogura, A J Wilkinson
Mar 1, 2003·Neurobiology of Disease·Kevin RostasyJohn C Hedreen
Mar 4, 2003·Nature Reviews. Molecular Cell Biology·Lars Ellgaard, Ari Helenius
Jun 5, 2003·The Biochemical Journal·Zhonghua LiuMichal Zolkiewski
Jul 23, 2004·Human Molecular Genetics·Young-Ho KohBarry Ganetzky
Sep 30, 2004·Annals of Neurology·Kevin St P McNaughtC Warren Olanow
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Gonzalo E TorresMarc G Caron
Nov 19, 2004·Human Molecular Genetics·P ShashidharanC W Olanow
May 20, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Vladimir I CheferToni S Shippenberg
Jun 3, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nutan SharmaXandra O Breakefield
Jun 16, 2005·Progress in Neurobiology·David SulzerAurelio Galli
May 26, 2006·Handbook of Experimental Pharmacology·J M Williams, A Galli
Aug 10, 2006·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Elissa M StromeDoris J Doudet
Oct 19, 2006·Neuroscience Research·Mai T DangYuqing Li
Apr 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey W HewettXandra O Breakefield
Jun 7, 2007·Journal of Neurochemistry·Aygul BalciogluDavid G Standaert
Jun 3, 2008·Experimental Neurology·Thomas Wichmann

❮ Previous
Next ❯

Citations

Oct 24, 2013·Brain : a Journal of Neurology·Brian D BermanKristina Simonyan
Aug 11, 2012·PloS One·Nicole BodePedro Gonzalez-Alegre
Dec 8, 2010·Neurobiology of Disease·D Cristopher BraggNutan Sharma
Nov 18, 2010·Neurobiology of Disease·Mark S LeDoux
Jul 16, 2010·Journal of Neurochemistry·Li BaoMargaret E Rice
Jul 31, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Janneth OleasYuqing Li
Jul 31, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Mark S LedouxThomas T Warner
Jun 5, 2012·Neurobiology of Disease·Chang-Hyun SongH A Jinnah
Feb 24, 2015·Progress in Neurobiology·K L Eskow JaunarajsA Pisani
Dec 18, 2013·Neuroscience·C N PrudenteH A Jinnah
Jun 12, 2013·Neuroscience Letters·Sadahiro IwabuchiN Charles Harata
Jul 19, 2014·Progress in Neurobiology·Franziska Richter, Angelika Richter
Nov 2, 2013·Neurologic Clinics·Jeffrey L Waugh, Nutan Sharma
Jan 21, 2019·Biomedical Chromatography : BMC·Hiroaki Yamaguchi, Nariyasu Mano
Jul 1, 2017·Frontiers in Systems Neuroscience·Chelsea N ZimmermanAntonio Pisani
Jan 19, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Chiara MelisMichelle E Ehrlich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.